MichBio

10/13/2026

We’re getting closer to BioMixer™ Traverse City! Don’t miss your chance to connect with Michigan’s life sciences community on Thursday, October 15 at Mammoth Distilling.

📅 October 15 | 5:00–7:00 PM
📍 Mammoth Distilling

Registration is FREE: https://ow.ly/vcBV50ZPEMU

10/12/2026

Changes to Medicare drug pricing could impact biotechnology innovation.

CMS has finalized its GLOBE drug pricing model, narrowing the original proposal. MichBio and BIO remain concerned about potential impacts on research investment, drug development and U.S. competitiveness.

Read more:

CMS has finalized its Global Benchmark for Efficient Drug Pricing (GLOBE) Model, establishing a mandatory Medicare demonstration that uses international drug prices to calculate manufacturer rebates for certain physician-administered medicines. Although the final rule substantially narrows the origi...

10/09/2026

Make new connections in Northern Michigan at BioMixer™ Traverse City! Whether you’re looking to expand your network, exchange ideas, or connect with others working across Michigan’s life sciences industry, BioMixer brings the community together in a relaxed setting.

Join MichBio and Avantor on October 15 at Mammoth Distilling in Traverse City.

Registration is FREE: https://ow.ly/vcBV50ZPEMU

10/08/2026

New approaches to drug development are gaining momentum.

The newly launched National Center to Accelerate Cures aims to advance New Approach Methodologies (NAMs), helping companies strengthen research decisions and accelerate innovation.

Learn what this could mean for Michigan's biotechnology industry: https://www.michbio.org/news/new-nam-center-could-help-companies-strengthen-drug-development-decisions

10/07/2026

What will Michigan’s next governor do to strengthen the state’s life sciences industry?

MichBio asked Michigan’s major-party gubernatorial candidates to weigh in on the issues that matter to our industry — from innovation and commercialization to talent, manufacturing, investment, regulatory policy and Michigan’s overall competitiveness.

We invited both candidates to respond to the same questions, and we’re sharing their answers directly with Michigan’s life sciences community.

As a nonpartisan organization, MichBio does not endorse candidates. Our goal is to help industry leaders, innovators, researchers and other stakeholders better understand where the candidates stand on policies that could shape the future of Michigan’s bio-industry.

Read the candidates’ responses and see how their visions for Michigan’s life sciences future compare.
https://www.michbio.org/news/competing-for-michigans-life-sciences-future-the-gubernatorial-candidates-weigh-in

10/06/2026

The Fall 2026 issue of BioMatters® is out now!

Michigan’s life sciences industry is powered by the people, companies and ideas turning innovation into impact — and our latest issue puts some of that incredible work in the spotlight.

Inside, we highlight organizations from across Michigan’s life sciences ecosystem, including Keystone Solutions Group, Wacker Chemical Corporation USA, M3D, SterileState, Pliant Medical, NorthernBio, and Oxford Biomedical Research, Inc., sharing the innovations, expertise and perspectives helping move our industry forward.

Read the Fall 2026 issue of BioMatters® and see what’s happening across Michigan’s life sciences community. https://issuu.com/michbio/docs/biomatters_fall_2026

10/05/2026

What separates a promising idea from a market-changing healthcare innovation?

Join us at BioArbor® on October 14 for “Seeing What Others Miss: Lessons from a Physician, Entrepreneur & Venture Investor,” featuring Louis Cannon, MD, Founder & CEO of Biostar Capital, in conversation with moderator Micaela Trexler, PhD.

Drawing on decades of experience across medicine, entrepreneurship, invention and venture investment, Dr. Cannon will share insights on identifying unmet clinical needs, evaluating emerging technologies, attracting investment and translating innovation into commercial success.

Wednesday, October 14, 5–7 PM
Plymouth Green Innovation Community | Ann Arbor

Connect with Michigan’s life sciences community and gain practical insights from someone who has experienced healthcare innovation from multiple sides of the table.

Register today: https://www.michbio.org/events/bioarbor-october-2026

09/29/2026

We’re excited to welcome our exhibitors to the 2026 Michigan Medical Device Summit™ tomorrow!

Thank you to the companies and organizations joining us to showcase their expertise, technologies, products, and services. Attendees, be sure to visit the exhibit area throughout the day to connect and see what they have to offer.

Not registered yet? There’s still time to join us tomorrow in Ann Arbor!

Register today: https://www.michbio.org/medical-device-summit

09/24/2026

PDUFA VIII could help shape a more predictable and efficient FDA review process for drugs and biologics, with implications for companies across the life sciences industry.

Learn more about what the proposed framework could mean for drug developers:

The Prescription Drug User Fee Act, or PDUFA, allows the U.S. Food and Drug Administration (FDA) to collect fees from pharmaceutical and biotechnology companies to help fund its review of new drugs an

09/23/2026

How do drug safety, biomedical research and ecosystem health intersect?

Join the world premiere of “The Coalition,” a new documentary exploring the use of horseshoe crab blood in drug safety testing, the impact on coastal ecosystems, and the growing conversation around more sustainable alternatives.

The 20-minute screening will be followed by a panel discussion featuring perspectives from biomedical research, conservation, academia and filmmaking.

📅 September 28 | 4:30–6:00 PM
📍 Michigan Theater | Ann Arbor
🎟️ Free and open to the public; reservations recommended (https://www.climateweek.umich.edu/)

The event is part of University of Michigan Climate Week 2026.